Finance

Beta
Lists
402A:TYO
Axelspace Holdings Corp
¥708.00
-3.80%
(-28.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 402A...
Open
¥751
High
¥751
Low
¥705
Mkt. cap
47.11B
Avg. vol.
5.70M
Volume
3.94M
52-wk high
¥1,141
52-wk low
¥409
EPS
-¥71
No. of employees
182
Open
¥751
High
¥751
Low
¥705
Mkt. cap
47.11B
Avg. vol.
5.70M
Volume
3.94M
52-wk high
¥1,141
52-wk low
¥409
EPS
-¥71
No. of employees
182
News stories
From sources across the web
About Axelspace Holdings Corp
CEO-
Employees182
FoundedMar 2, 2020
Headquarters-
SectorAerospace and Defense
Websiteaxelspacehd.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
352.00M
308.00M
256.00M
403.00M
Cost of goods sold
336.00M
326.00M
243.00M
354.00M
Cost of revenue
336.00M
326.00M
243.00M
354.00M
Research and development expenses
1.34B
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-577.00M
1.05B
1.14B
1.17B
Operating expense
761.00M
1.05B
1.14B
1.17B
Total operating expenses
1.10B
1.37B
1.38B
1.52B
Operating income
-745.00M
-1.06B
-1.13B
-1.12B
Other non operating income
3.00M
-47.00M
483.00M
1.00M
EBT including unusual items
-884.00M
-1.42B
-792.00M
-1.24B
EBT excluding unusual items
-830.00M
-1.19B
-721.00M
-1.20B
Income tax expense
-
1.00M
1.00M
3.00M
Effective tax rate
-
-0.07%
-0.13%
-0.24%
Other operating expenses
-
-
-
-
Net income
-884.00M
-1.42B
-793.00M
-1.24B
Net profit margin
-251.14%
-461.69%
-309.77%
-308.19%
Earnings per share
-
-
-
-
Interest and investment income
-
3.00M
-
12.00M
Interest expense
-85.00M
-83.00M
-85.00M
-90.00M
Net interest expenses
-85.00M
-80.00M
-85.00M
-78.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer